IBD Of mice and men-shedding new light on IL-13 activity in IBD

被引:10
作者
Danese, Silvio [1 ]
机构
[1] IRCCS Humanitas, IBD Ctr, I-20089 Milan, Italy
关键词
NK-T-CELLS; ULCERATIVE-COLITIS;
D O I
10.1038/nrgastro.2011.17
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
A recent study in a mouse model of colitis has demonstrated that interleukin (IL)-13, through inhibition of the mixed type 1 and type 17 T-helper cell inflammatory response, has a protective effect. the decoy receptor Il-13R alpha 2 inhibits this protective effect, suggesting blockade of IL-13R alpha 2 as a potential therapy for patients with IBD.
引用
收藏
页码:128 / +
页数:2
相关论文
共 10 条
[1]   Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis [J].
Arijs, I. ;
Li, K. ;
Toedter, G. ;
Quintens, R. ;
Van Lommel, L. ;
Van Steen, K. ;
Leemans, P. ;
De Hertogh, G. ;
Lemaire, K. ;
Ferrante, M. ;
Schnitzler, F. ;
Thorrez, L. ;
Ma, K. ;
Song, X. -Y R. ;
Marano, C. ;
Van Assche, G. ;
Vermeire, S. ;
Geboes, K. ;
Schuit, F. ;
Baribaud, F. ;
Rutgeerts, P. .
GUT, 2009, 58 (12) :1612-1619
[2]   IL-13 Signaling via IL-13Rα2 Induces Major Downstream Fibrogenic Factors Mediating Fibrosis in Chronic TNBS Colitis [J].
Fichtner-Feigl, Stefan ;
Young, Cheryl A. ;
Kitani, Atsushi ;
Geissler, Edward K. ;
Schlitt, Hans-Juergen ;
Strober, Warren .
GASTROENTEROLOGY, 2008, 135 (06) :2003-2013
[3]   Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody [J].
Fuss, IJ ;
Becker, C ;
Yang, ZQ ;
Groden, C ;
Hornung, RL ;
Heller, F ;
Neurath, MF ;
Strober, W ;
Mannon, PJ .
INFLAMMATORY BOWEL DISEASES, 2006, 12 (01) :9-15
[4]   Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis [J].
Fuss, IJ ;
Heller, F ;
Boirivant, M ;
Leon, F ;
Yoshida, M ;
Fichtner-Feigl, S ;
Yang, ZQ ;
Exley, M ;
Kitani, A ;
Blumberg, RS ;
Mannon, P ;
Strober, W .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (10) :1490-1497
[5]   Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution [J].
Heller, F ;
Florian, P ;
Bojarski, C ;
Richter, J ;
Christ, M ;
Hillenbrand, B ;
Mankertz, J ;
Gitter, AH ;
Bürgel, N ;
Fromm, M ;
Zeitz, M ;
Fuss, I ;
Strober, W ;
Schulzke, JD .
GASTROENTEROLOGY, 2005, 129 (02) :550-564
[6]   Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells [J].
Heller, F ;
Fuss, IJ ;
Nieuwenhuis, EE ;
Blumberg, RS ;
Strober, W .
IMMUNITY, 2002, 17 (05) :629-638
[7]   RETRACTED: Elevated IL-13Rα2 in Intestinal Epithelial Cells from Ulcerative Colitis or Colorectal Cancer Initiates MAPK Pathway (Retracted article. See vol. 21, pg. 1736, 2015) [J].
Mandal, Debasmita ;
Levine, Alan D. .
INFLAMMATORY BOWEL DISEASES, 2010, 16 (05) :753-764
[8]   Effector T cell plasticity: flexibility in the face of changing circumstances [J].
Murphy, Kenneth M. ;
Stockinger, Brigitta .
NATURE IMMUNOLOGY, 2010, 11 (08) :674-680
[9]   Colitis and Intestinal Inflammation in IL10-/- Mice Results From IL-13Rα2-Mediated Attenuation of IL-13 Activity [J].
Wilson, Mark S. ;
Ramalingam, Thirumalai R. ;
Rivollier, Aymeric ;
Shenderov, Kevin ;
Mentink-Kane, Margaret M. ;
Madala, Satish K. ;
Cheever, Allen W. ;
Artis, David ;
Kelsall, Brian L. ;
Wynn, Thomas A. .
GASTROENTEROLOGY, 2011, 140 (01) :254-+
[10]   Critical role of IL-17 receptor signaling in acute TNBS-induced colitis [J].
Zhang, Z ;
Zheng, M ;
Bindas, J ;
Schwarzenberger, P ;
Kolls, JK .
INFLAMMATORY BOWEL DISEASES, 2006, 12 (05) :382-388